FROST & SULLIVAN TO PERFORM MARKET STUDIES ON MBP

INGLEWOOD, CALIFORNIA, November 2, 2009 – Pharmaco-Kinesis Corporation (PKC), an advanced medical device company developing smart local drug delivery systems, today reported the engagement of Frost & Sullivan, the world leading provider of market research and technology analysis, to perform market studies and a revenue model for the Company’s Magnetic Breather Pump (MBP).

Frost & Sullivan were engaged to perform three tasks:

1. A Valuation of MPB for Use in Leptomeningeal Carcinomatosis

2. A Valuation of MBP for Preclinical Toxicology Use

3. A Revenue Model for the Application of the MBP for Leptomeningeal Carcinomatosis

The MBP is an implantable and remotely programmable pump that can deliver multiple medications directly to a tumor site or organ, with real time measurement of bioresponse in the form of VEGF levels, temperature and pressure.  These studies are expected to prove instrumental in the development and commercialization of the MBP.  The studies are expected to be completed in the second quarter of 2010.

Frost & Sullivan, founded in 1961, has more than 35 global offices with more than 1,800 industry consultants, market research analysts, technology analysts and economists. The mission is of Frost & Sullivan is to research and analyze new market opportunities for corporate growth. F&S is the world leader in growth consulting and the integrated areas of technology research, market research, economic research, corporate best practices, training, customer research, competitive intelligence, and corporate strategy.

For additional information, please contact:
Daniel Saks Senior
Vice President, Corporate Affairs
Pharmaco-Kinesis Corporation
(310) 734-4447